| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $1,050,046 ) |
| | 2024 | 2024 | THE UNIVERSITY OF QUEENSLAND | THE UNIVERSITY OF QUEENSLAND | ST LUCIA | | | | AUS | R01AR080354 | What causes low back pain to flare: Has a major opportunity to understand back pain been missed? | 000 | 3 | NIH | 9/12/2024 | $427,561 |
| | 2024 | 2024 | THE UNIVERSITY OF QUEENSLAND | THE UNIVERSITY OF QUEENSLAND | ST LUCIA | | | | AUS | R21AG080435 | Single molecule biomolecular condensate analysis in neurons | 000 | 2 | NIH | 1/9/2024 | $131,353 |
| | 2024 | 2024 | THE UNIVERSITY OF QUEENSLAND | THE UNIVERSITY OF QUEENSLAND | ST LUCIA | | | | AUS | R21AG080435 | Single molecule biomolecular condensate analysis in neurons | 001 | 2 | NIH | 6/11/2024 | $14,594 |
| | 2024 | 2024 | THE UNIVERSITY OF QUEENSLAND | THE UNIVERSITY OF QUEENSLAND | ST LUCIA | | | | AUS | R01AI162830 | Human-informed data-driven development of next-generation T cell vaccine against malaria | 000 | 3 | NIH | 8/20/2024 | $476,538 |
| | 2024 | 2022 | THE UNIVERSITY OF QUEENSLAND | THE UNIVERSITY OF QUEENSLAND | ST LUCIA | | | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 000 | 4 | FDA | 9/7/2024 | $0 |
| | 2024 | 2020 | THE UNIVERSITY OF QUEENSLAND | THE UNIVERSITY OF QUEENSLAND | ST LUCIA | | | | AUS | R21AI147020 | Exploring the effect of human blood microRNAs on mosquito biology | 000 | 2 | NIH | 11/15/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $737,523 ) |
| | 2023 | 2023 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | R21AG080435 | Single molecule biomolecular condensate analysis in neurons | 000 | 1 | NIH | 1/26/2023 | $145,947 |
| | 2023 | 2023 | THE UNIVERSITY OF QUEENSLAND | THE UNIVERSITY OF QUEENSLAND | ST LUCIA | | | | AUS | R01AI162830 | Human-informed data-driven development of next-generation T cell vaccine against malaria | 001 | 2 | NIH | 7/21/2023 | $487,101 |
| | 2023 | 2023 | THE UNIVERSITY OF QUEENSLAND | THE UNIVERSITY OF QUEENSLAND | ST LUCIA | | | | AUS | R01AR080354 | What causes low back pain to flare: Has a major opportunity to understand back pain been missed? | 000 | 2 | NIH | 8/24/2023 | $437,304 |
| | 2023 | 2022 | THE UNIVERSITY OF QUEENSLAND | THE UNIVERSITY OF QUEENSLAND | ST LUCIA | | | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 001 | 4 | FDA | 8/15/2023 | $0 |
| | 2023 | 2022 | THE UNIVERSITY OF QUEENSLAND | THE UNIVERSITY OF QUEENSLAND | ST LUCIA | | | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 000 | 4 | FDA | 4/7/2023 | $0 |
| | 2023 | 2020 | THE UNIVERSITY OF QUEENSLAND | THE UNIVERSITY OF QUEENSLAND | ST LUCIA | | | | AUS | RF1NS118406 | An integrated platform for studying sensory networks in the vertebrate brain | 000 | 1 | NIH | 12/29/2022 | -$332,829 |
|
| Issue Date FY: 2022 ( Subtotal = $330,440 ) |
| | 2022 | 2022 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 005 | 4 | FDA | 7/22/2022 | $250,000 |
| | 2022 | 2022 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | R01AR080354 | What causes low back pain to flare: Has a major opportunity to understand back pain been missed? | 000 | 1 | NIH | 9/22/2022 | $485,781 |
| | 2022 | 2021 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 004 | 3 | FDA | 2/9/2022 | $0 |
| | 2022 | 2021 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 003 | 3 | FDA | 1/31/2022 | $499,990 |
| | 2022 | 2021 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 000 | 3 | FDA | 11/23/2021 | $0 |
| | 2022 | 2021 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 003 | 3 | FDA | 1/31/2022 | $27,190 |
| | 2022 | 2020 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 002 | 2 | FDA | 1/31/2022 | -$499,990 |
| | 2022 | 2020 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | R21AI147020 | Exploring the effect of human blood microRNAs on mosquito biology | 000 | 2 | NIH | 5/25/2022 | $0 |
| | 2022 | 2020 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | RF1NS118406 | An integrated platform for studying sensory networks in the vertebrate brain | 000 | 1 | NIH | 8/29/2022 | -$405,341 |
| | 2022 | 2019 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | U01FD006522 | Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems | 000 | 2 | FDA | 1/10/2022 | $0 |
| | 2022 | 2019 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 001 | 1 | FDA | 1/31/2022 | -$27,190 |
|
| Issue Date FY: 2021 ( Subtotal = $250,000 ) |
| | 2021 | 2021 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 001 | 3 | FDA | 7/14/2021 | $250,000 |
| | 2021 | 2020 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 000 | 2 | FDA | 12/16/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,833,004 ) |
| | 2020 | 2020 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 002 | 2 | FDA | 8/5/2020 | $499,990 |
| | 2020 | 2020 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | R21AI147020 | Exploring the effect of human blood microRNAs on mosquito biology | 000 | 2 | NIH | 6/18/2020 | $128,341 |
| | 2020 | 2020 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | R01NS118406 | An integrated platform for studying sensory networks in the vertebrate brain | 001 | 1 | NIH | 9/16/2020 | $0 |
| | 2020 | 2020 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | R01NS118406 | An integrated platform for studying sensory networks in the vertebrate brain | 000 | 1 | NIH | 9/11/2020 | $1,204,673 |
| | 2020 | 2019 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 000 | 1 | FDA | 11/6/2019 | $0 |
| | 2020 | 2019 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 001 | 1 | FDA | 3/13/2020 | $0 |
| | 2020 | 2019 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | U01FD006522 | Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems | 000 | 2 | FDA | 1/10/2020 | $0 |
| | 2020 | 2019 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | U01FD006522 | Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems | 001 | 2 | FDA | 8/13/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $636,702 ) |
| | 2019 | 2019 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | U01FD006700 | Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations | 000 | 1 | FDA | 8/20/2019 | $250,000 |
| | 2019 | 2019 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | U01FD006522 | Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems | 001 | 2 | FDA | 7/19/2019 | $250,000 |
| | 2019 | 2019 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | R21AI147020 | Exploring the effect of human blood microRNAs on mosquito biology | 000 | 1 | NIH | 6/26/2019 | $161,995 |
| | 2019 | 2018 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | U01FD006522 | Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems | 000 | 1 | FDA | 2/8/2019 | $0 |
| | 2019 | 2016 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | R33AI098731 | Discovery of Polymyxin-based Antibacterial Agents Active Against Multi-Drug Resis | 000 | 5 | NIH | 2/8/2019 | -$25,293 |
|
| Issue Date FY: 2018 ( Subtotal = $250,000 ) |
| | 2018 | 2018 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | U01FD006522 | Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems | 001 | 1 | FDA | 8/29/2018 | $250,000 |
| | 2018 | 2018 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | U01FD006522 | Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems | 000 | 1 | FDA | 8/28/2018 | $250,000 |
| | 2018 | 2018 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | U01FD006522 | Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems | 001 | 1 | FDA | 8/29/2018 | -$250,000 |
| | 2018 | 2016 | THE UNIVERSITY OF QUEENSLAND | UNIVERSITY OF QUEENSLAND | BRISBANE | | 4072 | | AUS | R33AI098731 | Discovery of Polymyxin-based Antibacterial Agents Active Against Multi-Drug Resis | 000 | 5 | NIH | 3/21/2018 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $305,847 ) (Continued on the next page) |
|
